查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942435

人工器官市場規模、佔有率、趨勢及預測（按類型和地區分類，2026-2034年）

Artificial Organs Market Size, Share, Trends and Forecast by Type and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球人工器官市場規模達238億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到447億美元，2026年至2034年的複合年成長率（CAGR）為7.25%。北美地區目前佔據市場主導地位，預計2025年將佔據超過45.0%的市場。這主要歸功於3D生物列印技術需求的不斷成長（該技術能夠最大限度地降低器官排異風險）、癌症、糖尿病、高血壓、中風、心臟病和呼吸系統疾病等慢性病盛行率的上升，以及器官移植需求的不斷成長。

醫療技術的進步和慢性病的日益增加正在推動人工器官市場的成長。關鍵因素包括糖尿病、心血管疾病和肝病等疾病導致的器官衰竭發生率不斷上升。這些健康問題推動了對人工器官的需求，人工器官為等待器官移植的患者提供了挽救生命的選擇。 3D生物列印和生物人工器官開發等技術進步也正在推動市場成長。更有效率、更個人化的解決方案能夠改善治療效果並減少併發症。融合機器人和人工智慧技術的義肢和器官系統正在增強功能並提高普及率。另一個強勁的促進因素是人口老化，隨著老齡化，老年人面臨更大的器官相關疾病風險。此外，醫療基礎設施投資的增加以及人們對器官替代技術的日益了解，將進一步推動該市場的擴張。政府的支持性政策和適當的監管核准也為創新產品的快速商業化鋪平了道路。

美國已成為人工器官的主要區域市場。其強大的醫療保健基礎設施和大量的研發投入正在推動該領域的創新。腎衰竭和心血管疾病等慢性病的高發生率，以及漫長的器官移植等待名單，促使人們對人工心臟和透析機等替代方案的需求不斷成長。政府的各項舉措，例如對生物工程和醫療設備的資助，進一步推動了市場成長。中國醫療保健產業的快速發展也是推動市場成長的重要力量。人口老化和生活方式的改變導致慢性病盛行率上升，加上醫療費用支出不斷增加，加速了人工器官的普及應用。中國也受惠於技術合作以及本土製造商開發出經濟高效的人工器官解決方案。歐洲市場也得益於強而有力的監管支持和對創新醫療解決方案的資金投入。德國、法國和義大利等國的人口老化推動了對先進器官替代技術的需求成長。此外，歐洲對醫療設備生物相容性和永續性的重視，也推動了生物人工器官和3D列印技術的進步。

人造器官市場趨勢：

3D生物列印技術的進展

3D生物列印領域的創新對器官移植至關重要，它被用於開發人工器官。 3D生物列印因其能夠最大限度地降低器官排斥風險而備受關注。此外，人工器官與人工智慧（AI）的融合正在改變全球人工設備的格局。許多國家正致力於發展用於個體化評估器官與供體相容性的工具。這些工具能夠支持器官捐贈決策，並有助於確定患者是否應該接受捐贈器官或等待更好選擇。此外，考慮到生物組織結構的異質性，許多前沿的3D生物列印方法，例如植入式生物列印和多材料生物列印，已被提案用於構建具有複雜形狀、成分和功能性微血管網路的複雜組織和器官。此外，人們對器官和組織生物列印、細胞再生策略、細胞修復和再生以及用於下一代設備的功能性生物材料的日益關注，正在推動市場前景的良好發展。因此，能夠確保充足氧氣供應和營養物質輸送的生物反應器的發展，正在推動人工器官市場的成長。

慢性病發生率呈上升趨勢

包括癌症、糖尿病、高血壓、中風、心臟病、呼吸系統疾病、關節炎、肥胖症和口腔疾病在內的慢性疾病發生率不斷上升，推動了對人工器官的需求。人工器官為器官衰竭或功能障礙的患者提供了生存的希望。由於慢性疾病最終會導致器官衰竭，而器官捐贈者的數量有限，因此對人工器官的需求日益成長。為此，人工器官和仿生植入物正被用作一種替代療法，在提供救命治療的同時，減少對器官捐贈者的依賴。此外，心血管疾病盛行率的上升也推動了對人工心臟的需求，以取代受損的心室和瓣膜，這為行業投資者創造了巨大的成長機會。人工心臟的心室由聚氨酯製成，這是一種用途廣泛的合成材料，具有耐用、柔軟性和高度可靠的特性。

器官移植需求不斷成長

全球末期器官衰竭病例的不斷增加，導致器官移植需求日益成長，從而推動了市場前景。器官捐贈統計顯示，2023年共進行了超過46,000例器官移植手術。 2024年，美國國家器官移植等待名單上將有超過103,223名男性、女性和兒童等待移植。此外，腎臟移植作為透析的替代方案，以及用於治療不可逆轉的肝臟、心臟和肺部疾病患者的挽救性器官移植需求不斷成長，都在推動市場成長。器官移植是治療方法末期不可逆轉器官衰竭的最佳方法。Cyclosporine的引入改善了移植效果，全球固態器官移植計畫的數量也不斷增加，這些都對市場產生了積極影響。此外，移植計畫的實施提高了民眾的器官捐贈意願，並促使各醫療系統最佳化移植臨床實務和經濟措施。這些措施旨在提高固態器官移植受者的平均壽命、臨床狀況和生活品質。

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章 引言

第5章 全球人工器官市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：按類型
  • 市場區隔：依地區分類
  • 市場預測
  • SWOT分析
  • 價值鏈分析
  • 波特五力分析

第6章 按類型分類的市場區隔

  • 人工腎臟
  • 人工心臟
  • 人工胰臟
  • 人工電子耳
  • 其他

第7章 按地區分類的市場區隔

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第8章 競爭情勢

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abiomed, Inc.
    • HeartWare International, Inc.
    • Edwards Lifesciences Corp
    • Boston Scientific Corporation
    • Cochlear Limited
Product Code: SR112026A833

The global artificial organs market size reached USD 23.8 Billion in 2025. Looking forward, the IMARC Group expects the market to reach USD 44.7 Billion by 2034, exhibiting a growth rate CAGR of 7.25% during 2026-2034. North America currently dominates the market, holding a market share of over 45.0% in 2025. The increasing need for 3D bioprinting due to its capability to minimize the risk of organ rejection, rising prevalence of chronic diseases, such as cancer, diabetes, hypertension, stroke, heart disease, and respiratory diseases, and escalating demand for organ transplantation.

Advances in medical technology and the growing incidence of chronic diseases are contributing to the growth of the artificial organ market. Key factors include the increasing incidence of organ failures caused by conditions such as diabetes, cardiovascular diseases, and liver disorders. Such health issues increase the demand for artificial organs, as these are a life-saving option for patients waiting for a transplant. Technological advances in the form of 3D bioprinting and bioartificial organ development are also propelling market growth. More efficient, patient-specific solutions improve outcomes and reduce complications. Prosthetic and organ system technologies with embedded robotics and artificial intelligence enhance functionality, increasing adoption rates. Another strong driver is the elderly population, as this demographic is at a higher risk for organ-related problems as they age. Furthermore, investment in healthcare infrastructure is also growing, coupled with an awareness about organ replacement technologies that will fuel expansion in this market. Governments' supporting initiatives and suitable regulatory approvals also pave the way for the fast commercialization of innovative products.

The United States has emerged as a key regional market for artificial organs. The United States, a robust healthcare infrastructure and significant investments in research activities drive innovation in artificial organs. High rates of chronic diseases like kidney failure and cardiovascular issues, coupled with long transplant waiting lists, have amplified the demand for alternatives such as artificial hearts and dialysis machines. Government initiatives, like funding for bioengineering and medical devices, further support market growth. Moreover, China's rapidly expanding healthcare sector is also propelling the market. The growing prevalence of chronic diseases due to aging and lifestyle changes, combined with increasing healthcare spending, accelerates adoption. China also benefits from technological collaborations and the rise of local manufacturers developing cost-effective solutions for artificial organs. Furthermore, Europe's market is bolstered by strong regulatory support and funding for innovative healthcare solutions. Aging populations across countries like Germany, France, and Italy have led to increased demand for advanced organ replacement technologies. Furthermore, Europe's emphasis on biocompatibility and sustainability in medical devices drives advancements in bioartificial organs and 3D printing.

Artificial Organs Market Trends:

Advancements in 3D bioprinting

Innovations in the field of 3D bioprinting are crucial in organ transplanting as it is used for developing artificial organs. 3D bioprinting is gaining traction due to its capability to minimize the risk of organ rejection. In addition, the integration of artificial intelligence (AI) in artificial organs is transforming the global trends for artificial devices. Moreover, many countries are focusing on a tool that provides a customized assessment of organ and donor suitability. This tool can be very helpful in making effective decisions about organ retrieval while assisting patients in deciding if they should accept donor organs or wait for better options. Moreover, numerous cutting-edge 3D bioprinting methods, such as embedded bioprinting and multimaterial bioprinting approaches, have been proposed to create complex tissues and organs with intricate geometry, complex compositions, and functional microvasculature, in light of the heterogeneous constructs and diversity of native tissues. Furthermore, the growing focus on bioprinting organs and tissues, recellularization strategies, cellular repair or regeneration, and new functional biomaterials for the next generation of devices is offering a favorable market outlook. In line with this, the development of bioreactors to provide adequate oxygenation and guarantee transport of nutrients is bolstering the artificial organs market growth.

Increasing prevalence of chronic diseases

The rising incidence of chronic diseases such as cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases is driving the demand for artificial organs. They offer a way to save patients who are experiencing organ failure or functional incapacitation. With the eventual organ failure due to chronic diseases, there is an increase in the demand for artificial organs, but the supply of organ donors is limited. Therefore, artificial organs and bionic plants are used as alternatives that provide life-saving treatments with reduced dependency on organ donors. In addition, the growing demand for artificial hearts due to the increasing incidence of cardiovascular diseases to replace damaged heart ventricles and valves is also providing significant growth opportunities for industry investors. Artificial hearts have ventricles made from polyurethane, a very commonly used artificial material that is both durable and flexible, which makes it highly dependable.

Rising demand for organ transplantation

The increasing demand for organ transplants due to increased cases of end-stage organ failure throughout the world is driving a conducive market outlook. More than 46,000 transplants took place in 2023 according to the Organ Donation Statistics. In 2024, more than 103,223 men, women, and children awaited transplant placement on the US national waiting list. In addition, the rising demand for renal transplantation over dialysis, along with the escalating demand for lifesaving transplants to treat patients suffering from liver, heart, or lung irreversible diseases, is strengthening the growth of the market. Besides this, organ transplantation is the best therapy for terminal and irreversible organ failure. Besides, the introduction of cyclosporine to enhance transplant outcomes, along with the increasing number of solid organ transplant programs worldwide, is positively impacting the market. In addition, the implementation of transplant programs helps motivate people toward organ donation and defines the optimization of transplant clinical practices and an economic effort by the different healthcare systems. This was aimed at enhancing the life expectancy, clinical condition, and quality of life of recipients of solid organ transplants.

Artificial Organs Industry Segmentation:

Analysis by Type:

  • Artificial Kidney
  • Artificial Heart
  • Artificial Pancreas
  • Cochlear Implants
  • Others

The artificial kidney dominates the market in 2025 due to an increasing number of patients needing renal replacement therapy. Moreover, lifestyle diseases such as diabetes, hypertension, and metabolic syndrome are catalyzing the demand for artificial kidneys. Kidney transplantation, whenever feasible, is the most preferred mode of RRT. This leads to the increased demand for artificial kidneys that can be wearable or implantable, performing the complete excretory, filtration, tubular, endocrine, and metabolic functions of the kidney while maintaining the quality of life and minimizing complications.

The artificial heart is a device that maintains blood circulation and oxygenation in the human body for an extended period. It can be used by people having conditions, such as uncontrollable ventricular arrhythmia, end-stage complications of congenital heart defects, ventricles that are not the right shape for a ventricular assist device (VAD), broken or ruptured ventricles, a left ventricle that fails to work properly after a mechanical valve replacement surgery, and blood clots in the lining of the blood vessels and heart. It is very helpful for heart patients as it is made of material from which the body usually doesn't reject.

An artificial pancreas consists of three parts that work in concordance to replicate what a healthy pancreas is supposed to do when keeping blood glucose levels under the body's control. It has mainly been used to manage type 1 diabetes. However, it uses a CGM, which measures glucose levels in the blood, every few minutes using an extremely small sensor implanted just underneath the skin. The sensor wirelessly transmits the information to a program saved on either a smartphone or an insulin infusion pump. The small amounts of insulin are administered from the insulin infusion pump for the entire day whenever the glucose levels in the blood are outside the target range.

Cochlear implants are small electronic devices that have enabled people to hear sound. They can help improve the understanding of speech using less lip reading and be able to perceive sounds as they directly stimulate the non-functioning part of the ear by applying a mild electrical current to the structures of the cochlea.

Regional Analysis:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

North America had the highest artificial organs market share of over 45.0% in 2025. The market share is primarily dominated by North America, as the number of transplant surgeries is on the rise there. Additionally, artificial organs are in high demand due to the increasing rate of organ failure, which is further contributing to this market. Other drivers behind the growth of this market are the development of well-crafted health facilities in this area, the local existence of various prominent companies in biotechnology, and the medical device market, among other factors. Added to these is the high number of donors and demand for kidney transplant cases in the area.

The growing aging population in Europe is providing a conducive market outlook. An aging population increases the incidence of chronic diseases and organ failure due to advancing age, which accelerates the demand for artificial organs to cater to the healthcare requirements of this population. Also, the increasing burden of heart disease and end-stage kidney and lung disorders is influencing the market positively. Along with this, increasing demand for medical bionic implants and artificial organs is on account of the surging use of bionic prosthetic devices which is bolstering the market growth in this region.

Asia-Pacific will grow significantly due to an extensive consumer base, soaring government initiatives in enhancing the healthcare system, and an average disposable income in the country. In addition, the rising awareness among the masses about the advantages of organ transplantation is boosting the growth of the market. Apart from this, the governing agencies in the region are promoting domestic medical devices at a high level of legitimacy in the global context, allowing key players to expand their overseas footprint, attract international talent, and scale up clinical research programs.

With an increase in chronic conditions, such as cardiovascular diseases, diabetes, and kidney disorders, comes an increase in the demand for artificial organs in the Middle East and Africa region. Artificial organs, such as the heart and pancreas, grant patients a better quality of life and longer life spans than otherwise. Furthermore, the Middle East and Africa region experience a shortage of viable organs for transplantation. Artificial organs are a bridge to transplantation, providing patients with critical support until a suitable donor organ becomes available. In addition, the growth of the market is being impelled by advancements in materials science, miniaturization, and biotechnology.

Increased prevalence of organ failure due to blood loss, drug addiction, severe trauma, poor habits related to sanitation, and genetic deformities are positively affecting the market in the Latin America region. Lifestyle disorders such as eating habits, smoking, consumption of alcohol, stress, and lack of exercise are the factors contributing to the growth of the market in the region.

Key Regional Takeaways:

United States Artificial Organs Market Analysis

In 2025, the United States holds 82.30% of the artificial organ market in North America. The increase in the incidence of organ failure, along with advancement in the medical technology sector, is the leading factor driving the artificial organs industry in the US. Organ failure, more so kidney and heart failure, is increasingly on the rise within the United States due to the ever-increasing prevalence of chronic diseases such as diabetes, hypertension, and heart problems. According to data from the National Kidney Foundation, more than 37 Million Americans suffer from chronic kidney disease, but more than three-quarters of the population are unaware of having it. More than 120,000 people remain on the national organ transplant waiting list, with over 98,000 waiting for a life-saving kidney. There is a growing scarcity of donor organs and an increasing demand for artificial alternatives like prosthetic hearts, kidneys, and lungs.

Good health infrastructure, heavy medical spending, and medical innovation and research efforts favor the U.S. market. The FDA has fast-tracked approval processes for some artificial organs like SynCardia Total Artificial Heart and AbioCor Artificial Heart. For starters, bioengineering and regenerative medicine are heavily financed, which propels innovations in the market for artificial organs. With an ever-aging population and rapidly increasing healthcare expenditures, alternative organ transplants will push this demand for artificial organs sky-high. Finally, alliances involving private businesses, medical centers, and academic institutions foster and increase this market.

Europe Artificial Organs Market Analysis

The market for artificial organs is expanding in Europe as a result of biotechnology breakthroughs, an aging population, and a rise in chronic illness. According to the WHO, the population aged 60 and older is rapidly growing with 215 Million in 2021, 247 Million by 2030, and 300 Million by 2050. The European Commission reports a severe lack of suitable donor organs, notwithstanding the increasing demand for organ transplants in the European market. To address this demand, nations like Germany, the UK, and France are concentrating on creating substitutes, such as artificial liver, kidney, and cardiac devices. The market is growing as a result of the European Society for Artificial Organs (ESAO) active promotion of research and development in this area.

Another important motivator is government financing for medical innovation. Research in bioengineering and regenerative medicine, which are essential for the creation of artificial organs, has received significant financing from the EU's Horizon 2020 initiative and other supported programs. Technological developments like better artificial organ materials and integration with intelligent healthcare systems also help the European market. The need for artificial organs is anticipated to increase as age-related ailments including diabetes and cardiovascular disorders become more common.

Asia Pacific Artificial Organs Market Analysis

The principal factors driving the market for artificial organs in the Asia-Pacific region include increased lifestyle disorders, the growth of elderly populations, and insufficient organ donation networks. For example, according to the Indian Council of Medical Research - India Diabetes (ICMR INDIAB) study of 2023, it was stated that the incidence of diabetes is 10.1 Crores. Similarly, China accounts for the highest diabetes population, with more than 118 million people diagnosed with the illness, and thus with close to 22% prevalence of global diabetes in the year 2021. A massive unmet demand exists in other countries, like China and India, where enormous populations alongside growing incidence rates of diabetes, cardiovascular disease, and renal diseases demand artificially constructed organs like an artificial kidney and hearts. Artificial organs have recently increased demand, and organ transplantation is still an emerging practice in China. Renal disease has increased tremendously in India, as per industry reports, and the demand for artificial kidney solutions has increased because of this. The market is expanding because of better healthcare infrastructure and technology. Countries such as Japan, being at the forefront of robotic surgery and regenerative medicine, are the ones who are going to play a big role in the artificial organ market. The Japanese healthcare system also has research in artificial organ technology, especially on substitutes for heart and kidney. The South Korean Ministry of Health and Welfare has also offered funding for projects that will promote the development of artificial organs and organ transplantation.

Latin America Artificial Organs Market Analysis

Increasing incidences of chronic diseases and an increased number of patients in need of organ transplantation have boosted the Latin America artificial organs market. A serious shortage of donors to cater to organ transplantation poses significant challenges to Brazil and Mexico, mainly due to countries having a high percentage of diabetes, hypertension, and cardiovascular disorders. The demand for artificial organs is on the rise as the Latin American region remains plagued by the persistent unavailability of kidney, liver, and heart transplants, according to the PAHO. The industry is also being driven by increased healthcare investments in countries like Brazil, Argentina, and Chile as they expand access to cutting-edge medical technologies. Additionally, the availability of artificial organ devices is being facilitated by regional hospitals through collaborations with global medical technology firms.

Middle East and Africa Artificial Organs Market Analysis

The rising prevalence of NCDs such as diabetes, chronic renal disease, and cardiovascular disease is driving the market for artificial organs across the Middle East and Africa. The International Diabetes Federation predicts that the Middle East and North Africa (MENA) Region has the highest regional prevalence at 16.2% and the second largest predictable growth (86%) in the number of persons with diabetes to reach 136 Million by 2045. The MENA Region presents the highest percentage, standing at 24.5% of diabetes-related mortality amongst persons of working age. Even though 13.6% of people worldwide have diabetes, only USD 32.6 Billion, or 3.4% of global spending, was spent on the disease in the MENA region. Limited access to organ donation burdens many governments in Africa, which is currently driving the industry due to the required reasonably priced healthcare solutions. The region is also advancing in medical technology areas through international partnerships and support by the likes of institutions like the World Bank and the African Development Bank.

Competitive Landscape:

The artificial organs market is highly fragmented with the presence of many large, small, and medium-scale vendors. In addition, key players are focusing on developing innovative products and regional expansion to gain maximum revenue share in the industry. Mergers and acquisitions (M&A) are supporting them to expand their existing product portfolio and increase their geographical footprints. Moreover, key manufacturers are evolving advanced artificial intelligence (AI) designs that can recognize patients who are expected to have a lesser gait speed outcome, after hip or knee surgical intervention. They are also introducing robotic technologies digitally designed to offer transformative data-powered clinical insights to boost patient outcomes, with strong predictive analytic capabilities. Furthermore, key players are focusing on the demonstration of a functional prototype of their implantable artificial kidneys, which is expected to positively influence the artificial organs market scope.

The report provides a comprehensive analysis of the competitive landscape in the artificial organs market with detailed profiles of all major companies, including:

  • Abiomed, Inc.
  • HeartWare International, Inc.
  • Edwards Lifesciences Corp
  • Boston Scientific Corporation
  • Cochlear Limited

Key Questions Answered in This Report

  • 1.What are artificial organs?
  • 2.How big is the artificial organs market?
  • 3.What is the expected growth rate of the global artificial organs market during 2026-2034?
  • 4.What are the key factors driving the global artificial organs market?
  • 5.What is the leading segment of the global artificial organs market based on the type?
  • 6.What are the key regions in the global artificial organs market?
  • 7.Who are the key players/companies in the global artificial organs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Organs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Region
  • 5.6 Market Forecast
  • 5.7 SWOT Analysis
    • 5.7.1 Overview
    • 5.7.2 Strengths
    • 5.7.3 Weaknesses
    • 5.7.4 Opportunities
    • 5.7.5 Threats
  • 5.8 Value Chain Analysis
    • 5.8.1 Overview
    • 5.8.2 Research and Development
    • 5.8.3 Raw Material Procurement
    • 5.8.4 Manufacturing
    • 5.8.5 Marketing
    • 5.8.6 Distribution
    • 5.8.7 End-Use
  • 5.9 Porters Five Forces Analysis
    • 5.9.1 Overview
    • 5.9.2 Bargaining Power of Buyers
    • 5.9.3 Bargaining Power of Suppliers
    • 5.9.4 Degree of Competition
    • 5.9.5 Threat of New Entrants
    • 5.9.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Artificial Kidney
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Artificial Heart
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Artificial Pancreas
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cochlear Implants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Europe
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Asia Pacific
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Middle East and Africa
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Latin America
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Competitive Landscape

  • 8.1 Market Structure
  • 8.2 Key Players
  • 8.3 Profiles of Key Players
    • 8.3.1 Abiomed, Inc.
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Description
      • 8.3.1.3 Product Portfolio
      • 8.3.1.4 Financials
      • 8.3.1.5 SWOT Analysis
    • 8.3.2 HeartWare International, Inc.
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Description
      • 8.3.2.3 Product Portfolio
      • 8.3.2.4 Financials
      • 8.3.2.5 SWOT Analysis
    • 8.3.3 Edwards Lifesciences Corp
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Description
      • 8.3.3.3 Product Portfolio
      • 8.3.3.4 Financials
      • 8.3.3.5 SWOT Analysis
    • 8.3.4 Boston Scientific Corporation
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Description
      • 8.3.4.3 Product Portfolio
      • 8.3.4.4 Financials
      • 8.3.4.5 SWOT Analysis
    • 8.3.5 Cochlear Limited
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Description
      • 8.3.5.3 Product Portfolio
      • 8.3.5.4 Financials
      • 8.3.5.5 SWOT Analysis

List of Figures

  • Figure 1: Global: Artificial Organs Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Organs Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Artificial Organs Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Artificial Organs Market: Breakup by Region (in %), 2025
  • Figure 5: Global: Artificial Organs Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 6: Global: Artificial Organs Industry: SWOT Analysis
  • Figure 7: Global: Artificial Organs Industry: Value Chain Analysis
  • Figure 8: Global: Artificial Organs Industry: Porter's Five Forces Analysis
  • Figure 9: Global: Artificial Organs (Artificial Kidney) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Artificial Organs (Artificial Kidney) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Artificial Organs (Artificial Heart) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Artificial Organs (Artificial Heart) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Artificial Organs (Artificial Pancreas) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Artificial Organs (Artificial Pancreas) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Artificial Organs (Cochlear Implants) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Artificial Organs (Cochlear Implants) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Artificial Organs (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Artificial Organs (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: North America: Artificial Organs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: North America: Artificial Organs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Europe: Artificial Organs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Europe: Artificial Organs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Asia Pacific: Artificial Organs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Asia Pacific: Artificial Organs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Middle East and Africa: Artificial Organs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Middle East and Africa: Artificial Organs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Latin America: Artificial Organs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Latin America: Artificial Organs Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Artificial Organs Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Artificial Organs Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Artificial Organs Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 4: Global: Artificial Organs Market Structure
  • Table 5: Global: Artificial Organs Market: Key Players